A Clinical Trial for Examining the Therapeutic Equivalence Between Fluticasone Propionate 100 mcg and Salmeterol 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 100/50 mcg Inhalation Powder/GSK in Patients With Asthma

NCT03676413 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

451

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Fluticasone Propionate 100 mcg and Salmeterol 50 mcg inhalation Powder/Respirent Pharmaceuticals
DRUG: ADVAIR DISKUS® 100/50 mcg inhalation powder pre-dispensed/GSK
DRUG: Placebo

Sponsor

Respirent Pharmaceuticals Co Ltd.